METASTATIC MALIGNANCY Clinical Trials

6 clinical trials for METASTATIC MALIGNANCY across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma — RECRUITING · PHASE1
• A PHASE 1/2, OPEN-LABEL, SAFETY, TOLERABILITY, PHARMACOKINETICS, AND ANTI-TUMOR ACTIVITY STUDY OF REPOTRECTINIB IN PEDIATRIC AND YOUNG ADULT SUBJECTS WITH ADVANCED OR METASTATIC MALIGNANCIES HARBORING ALK, ROS1, OR NTRK1-3 ALTERATIONS — RECRUITING · PHASE1
• A PHASE IA/IB OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF MTIG7192A AS A SINGLE AGENT IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC TUMORS — RECRUITING · PHASE1
• Yield of Cryoprobe vs Flexible Forceps Pleural Biopsy — COMPLETED · NA
• A PHASE 1B/2A TWO-PART OPEN-LABEL MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF LY2880070 AS MONOTHERAPY AND IN COMBINATION WITH GEMCITABINE IN PATIENTS WITH ADVANCED OR METASTATIC CANCER — COMPLETED · PHASE1
• A PHASE I, OPEN-LABEL, MULTICENTER, 3-PERIOD, FIXED-SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF VEMURAFENIB ON THE PHARMACOKINETICS OF A SINGLE DOSE OF TIZANIDINE (A CYP1A2 SUBSTRATE) IN PATIENTS WITH BRAFV600 MUTATION-POSITIVE METASTATIC MALIGNANCY. — COMPLETED · PHASE1

Refine this search